Castle Biosciences Inc (NASDAQ: CSTL) on Friday, soared 3.41% from the previous trading day, before settling in for the closing price of $17.02. Within the past 52 weeks, CSTL’s price has moved between $15.45 and $35.84.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 44.97%. The company achieved an average annual earnings per share of -515.86%. With a float of $27.94 million, this company’s outstanding shares have now reached $28.84 million.
The extent of productivity of a business whose workforce counts for 761 workers is very important to gauge. In terms of profitability, gross margin is 85.88%, operating margin of -3.97%, and the pretax margin is -0.64%.
Castle Biosciences Inc (CSTL) Insider and Institutional Ownership
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Castle Biosciences Inc is 3.21%, while institutional ownership is 91.53%. The most recent insider transaction that took place on Apr 21 ’25, was worth 94,851. In this transaction Pres. & Chief Exec. Officer of this company sold 4,408 shares at a rate of $21.52, taking the stock ownership to the 4,275 shares. Before that another transaction happened on Apr 21 ’25, when Company’s Pres. & Chief Exec. Officer sold 1,236 for $21.52, making the entire transaction worth $26,596. This insider now owns 74,627 shares in total.
Castle Biosciences Inc (CSTL) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -515.86% per share during the next fiscal year.
Castle Biosciences Inc (NASDAQ: CSTL) Trading Performance Indicators
Castle Biosciences Inc (CSTL) is currently performing well based on its current performance indicators. A quick ratio of 9.19 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.46. Likewise, its price to free cash flow for the trailing twelve months is 10.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.20, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -1.98 in one year’s time.
Technical Analysis of Castle Biosciences Inc (CSTL)
The latest stats from [Castle Biosciences Inc, CSTL] show that its last 5-days average volume of 0.41 million was inferior to 0.45 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 95.00%. Additionally, its Average True Range was 0.76.
During the past 100 days, Castle Biosciences Inc’s (CSTL) raw stochastic average was set at 15.99%, which indicates a significant decrease from 96.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.85% in the past 14 days, which was lower than the 50.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.45, while its 200-day Moving Average is $25.75. Now, the first resistance to watch is $17.77. This is followed by the second major resistance level at $17.94. The third major resistance level sits at $18.21. If the price goes on to break the first support level at $17.33, it is likely to go to the next support level at $17.05. The third support level lies at $16.88 if the price breaches the second support level.
Castle Biosciences Inc (NASDAQ: CSTL) Key Stats
Market capitalization of the company is 508.15 million based on 28,872K outstanding shares. Right now, sales total 332,070 K and income totals 18,250 K. The company made 87,990 K in profit during its latest quarter, and -25,850 K in sales during its previous quarter.
